Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF
No-Receipt date
2015-00607 - 26/02/2015
No-Filing date
20150400450 - 26/02/2015
No-Granting date
3085551 - 27/02/2015
No-EPO application date
13780100.7 - 11/10/2013
No-EPO granting date
2766048 - 10/12/2014
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
2/2015 - 18/03/2015
Expiration date
12/10/2033
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201261712928 P12/10/2012/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 47/48
A61P 35/00
C07D 487/04
C07D 519/00
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
460811
MEDLMMUNE LIMITED
MILSTEIN BUILDING
GRANTA PARK CAMBRIDGE CB21 6GH
UNITED KINGDOM (GREAT BRITAIN)
Inventors
Code
Firstname
Surname
1400652
HOWARD, PHILIP WILSON
Representatives
Code
Firstname
Surname
Address
Town
Zip
1349
ELENI
PAPAKONSTANTINOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
18/12/2015
Μεταβίβαση (7e802)
ΑΡ.ΠΡΩΤ. 6351/13-11-2015, ΚΩΔ.ΠΛΗΡ. 3458, ( ΜΕ ΤΗΝ ΥΠ'ΑΡΘ. RJW/FP6983605/21.09.2015, ΚΟΙΝΟΠΟΙΗΣΗ ΤΟΥ ΕΓΔΕ)
579639 Spirogen Sarl Rue Saint-Pierre2 ΕΛΒΕΤΙΑ 1003 Lausanne
460811 Medlmmune Limited Milstein Building ΗΝΩΜΕΝΟ ΒΑΣΙΛΕΙΟ (ΜΕΓΑΛΗ ΒΡΕΤΑΝΙΑ) Granta Park Cambridge CB21 6GH
Title Instruments
Payments history
13 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).